Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with …
C Sebban, N Mounier, N Brousse, C Belanger, P Brice… - Blood, 2006 - ashpublications.org
The purpose of this study is to compare our standard chemotherapy regimen (CHVP
[cyclophosphamide, doxorubicin, teniposide, and prednisone]) plus interferon with 4 courses …
[cyclophosphamide, doxorubicin, teniposide, and prednisone]) plus interferon with 4 courses …
High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a …
E Deconinck, C Foussard, N Milpied, P Bertrand… - Blood, 2005 - ashpublications.org
Doxorubicin-based immunochemotherapy, with interferon, has been shown to improve
survival in patients with advanced follicular lymphoma. High-dose chemotherapy with stem …
survival in patients with advanced follicular lymphoma. High-dose chemotherapy with stem …
[HTML][HTML] Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma
P Solal-Celigny, E Lepage, N Brousse… - … England Journal of …, 1993 - Mass Medical Soc
Background Interferon alfa and cytotoxic drugs have synergistic effects in patients with non-
Hodgkin's lymphoma. In 1986, we designed a clinical trial to evaluate the benefit of …
Hodgkin's lymphoma. In 1986, we designed a clinical trial to evaluate the benefit of …
Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results …
G Lenz, M Dreyling, E Schiegnitz, R Forstpointner… - Blood, 2004 - ashpublications.org
Conventional chemotherapy has failed to substantially prolong survival for patients with
advanced follicular lymphoma. To improve outcomes, the German Low-Grade Lymphoma …
advanced follicular lymphoma. To improve outcomes, the German Low-Grade Lymphoma …
High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a …
E Gyan, C Foussard, P Bertrand… - Blood, The Journal …, 2009 - ashpublications.org
Autologous stem cell transplantation (ASCT) as first-line therapy for follicular lymphoma (FL)
remains controversial. The multicenter study randomized 172 patients with untreated FL for …
remains controversial. The multicenter study randomized 172 patients with untreated FL for …
High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the …
P Brice, D Simon, R Bouabdallah, C Belanger… - Annals of oncology, 2000 - Elsevier
Background Among the 566 patients with follicular lymphomas (FL) included in the GELF 86
prospective trials from October 1986 to September 1995, 372 with progressive/relapsing …
prospective trials from October 1986 to September 1995, 372 with progressive/relapsing …
Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des …
P Solal-Céligny, E Lepage, N Brousse… - Journal of Clinical …, 1998 - ascopubs.org
PURPOSE To compare progression-free survival (PFS), overall survival (OS), and toxicity of
a doxorubicin-containing regimen administered alone or in combination with interferon alfa …
a doxorubicin-containing regimen administered alone or in combination with interferon alfa …
High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial
HC Schouten, W Qian, S Kvaloy, A Porcellini… - Journal of clinical …, 2003 - ascopubs.org
Purpose: To determine, in a randomized clinical trial, whether high-dose therapy (HDT)
followed by autologous stem-cell transplantation is more effective than standard treatment …
followed by autologous stem-cell transplantation is more effective than standard treatment …
Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d' …
P Brice, Y Bastion, E Lepage, N Brousse… - Journal of Clinical …, 1997 - ascopubs.org
PURPOSE To evaluate prospectively in patients with follicular lymphoma and a low tumor
burden three therapeutic options: delay of any treatment until clinically meaningful …
burden three therapeutic options: delay of any treatment until clinically meaningful …
[HTML][HTML] Autologous stem cell transplantation for patients with early progression of follicular lymphoma: a follow-up study of 2 randomized trials from the German Low …
V Jurinovic, B Metzner, M Pfreundschuh… - Biology of Blood and …, 2018 - Elsevier
Patients with follicular lymphoma (FL) and progression of disease (POD) within 24 months
after frontline treatment (POD24) have poor overall survival (OS). The optimal salvage …
after frontline treatment (POD24) have poor overall survival (OS). The optimal salvage …